Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
Michael ShpolianskyDirk RoggenbuckMarina PinskerNaomi SalamonBatia WeissDror S ShouvalLael WernerPublished in: Digestive diseases and sciences (2020)
A positive anti-GP2 level is highly associated with CD, while a negative result does not exclude CD. Additional studies are required to determine whether these markers can be used in pediatric patients with CD for risk stratification.
Keyphrases